LenioBio GmbH has been awarded EU4Health funding by the European Health and Digital Executive Agency (HaDEA), which implemented the corresponding call for proposals on behalf of the European Commission’s Health Emergency Preparedness and Response Authority (HERA). The project will focus on further development of the cell-free protein expression system, ALiCE®, as an innovative, rapid and on-demand…
Advanced NVIDIA GPU Integration Transforms Genome and Multiomics Alignment, Variant Calling and Reporting Capabilities Dante Omics AI, a pioneering force in computational genomics, today announced a groundbreaking upgrade to its proprietary genome and multiomics alignment, variant calling and reporting platform. The enhanced system leverages cutting-edge NVIDIA GPU technology to deliver unprecedented speed and accuracy in…
In a new article published in Value in Health, researchers from Analysis Group, a global leader in health economics and outcomes research (HEOR), collaborated with Novartis to examine how HEOR is transforming the evaluation and access pathways for cell and gene therapies (CGTs) for rare diseases. As CGTs move from experimental to increasingly approved treatments for rare…
Seamless analysis of high-dimensional multiomics and imaging data, alongside structured datasets, will drive the next wave of AI-driven scientific discovery. TileDB, the multimodal database pioneer, and Databricks, the Data and AI company, today announced a strategic partnership that eliminates data silos preventing healthcare and life sciences organizations from fully leveraging AI-driven drug discovery and clinical insights….
New collaboration between Aligning Science Across Parkinson’s and Allen Institute creates a common language for visualizing data from Parkinson’s and Alzheimer’s research Researchers now have a powerful new way to understand the types of brain cells that are affected in neurodegenerative diseases and to uncover connections between conditions such as Parkinson’s, Alzheimer’s, and other forms…
Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, today announced successful mapping of the Respiratory Syncytial Virus (RSV) genome using its proprietary BioSeeker discovery engine to address one of global health’s most persistent and costly viral threats. By pinpointing highly conserved genomic targets, this mapping…
Galatea Bio and Fabric Genomics, a GeneDx company, announced today a strategic collaboration to enhance genetic testing by incorporating both rare pathogenic variant analysis and polygenic risk scoring (PRS) to assess genetic susceptibility to common diseases. The initial offering will include an inherited cardiovascular gene panel based on American Heart Association (AHA) recommendations, with additional PRS for cardiovascular related…
AI meets genomics in BioAro’s latest launch, unlocking faster, scalable drug discovery.PanOmiQ Research sets a new global benchmark for precision health innovation. BIO International Convention In a bold move that may redefine the global future of genomics, drug discovery, and precision health, BioAro Inc., a Canadian biotechnology and precision medicine company, unveiled its expanded PanOmiQ platform today at the…
Appointment strengthens leadership team to drive strategy focused on harnessing 3D multi-omics to identify high-confidence, high-value therapeutic targets, to accelerate drug discovery Enhanced Genomics (‘Enhanced’ or ‘the Company’), the biotechnology company pioneering 3D multi-omics to rapidly identify high-confidence, genetically validated drug targets for common diseases, today announced the appointment of Dietrich Stephan, Ph.D. as Chair…